September 2026: Beijing Taps Tobacco Monopoly for ¥260 Billion State Bank Capital Injection
Beijing is mobilizing state-owned cigarette monopoly China National Tobacco Corporation alongside the Ministry of Finance to execute a combined ¥260 billion ($38.7 billion) capital injection into two of the nation’s largest state lenders. The move aims to bolster core Tier 1 capital across the financial sector through private placements of A-shares, which are subject to a five-year lock-up period as long-term capital. Under the recapitalization plan, the Ministry of Finance will commit ¥200 billion ($29.8 billion), while China Tobacco and its subsidiaries will provide the remaining ¥60 billion ($8.9 billion), split equally between the two institutions.
Industrial and Commercial Bank of China, the world’s largest bank by assets, will raise up to ¥100 billion ($14.9 billion) through its private placement, anchored by ¥70 billion ($10.4 billion) from the Ministry of Finance and ¥30 billion ($4.5 billion) from China Tobacco. Meanwhile, Agricultural Bank of China will execute a ¥160 billion ($23.8 billion) private placement, receiving ¥130 billion ($19.3 billion) from the Ministry of Finance and ¥30 billion ($4.5 billion) from the tobacco giant.
China Tobacco holds a virtual monopoly over the domestic market and serves as a vital source of sovereign liquidity, having generated ¥1,657 billion ($246.6 billion) in industry-wide taxes and profits in 2025. This transaction marks a continued expansion of the monopoly’s balance sheet into state financial institutions. Following a ¥7.58 billion ($1.13 billion) investment in Bank of Communications in March 2025, China Tobacco’s cumulative commitments across major Chinese banks have reached ¥78 billion ($11.6 billion).
January 2026: China National Tobacco’s Record Fiscal Contribution Underscores Its Central Role in State Finances
China National Tobacco Corporation (CNTC) made a record fiscal contribution to China’s state finances in 2025, reinforcing its position as one of the single most important revenue sources for the central government. According to official data released by the State Tobacco Monopoly Administration, fiscal contributions to the state budget reached CNY1.58 trillion (US$222 billion) in 2025, representing a 2.3% increase from the previous year. Combined industrial and commercial taxes and profit remittances totaled CNY1.657 (US$232 billion) trillion, up 3.5% year on year. Both figures marked the highest levels ever recorded for the Chinese tobacco monopoly. The difference between the two reflects accounting distinctions between fiscal revenue booked directly into the state budget and the broader measure that includes retained profits transferred to the government.
The scale of CNTC’s contribution becomes even clearer when viewed against national budget figures. According to data published by China’s Ministry of Finance, national general public budget revenue is around CNY22 trillion. On this basis, CNTC’s fiscal contribution in 2025 would be equivalent to about 7.2% of total national general public budget revenue, an exceptionally high share for a single industry. This proportion is broadly consistent with historical estimates suggesting that the tobacco sector accounts for between 7% and, in some years, close to 10% of China’s total government revenue.
CNTC’s outsized fiscal role is closely linked to China’s unique tobacco governance model. As a state-owned monopoly operating under the State Tobacco Monopoly Administration, CNTC dominates the domestic cigarette market with c.98% share. Unlike in liberalized markets, where governments primarily benefit through excise and consumption taxes, China’s system allows the state to capture both tax revenue and corporate profits. This structure helps explain why China’s tobacco-related fiscal intake far exceeds that of any other country in absolute terms.
The record 2025 contribution also comes against a backdrop of modest change in volume, steady price increases, and continued premiumization in the domestic cigarette market. At the same time, it highlights the persistent policy tension facing Chinese authorities: tobacco remains a critical pillar of fiscal revenue and regional employment, particularly in major tobacco-growing provinces, even as public health goals and international commitments under the WHO Framework Convention on Tobacco Control call for stricter tobacco control measures. Overall, the 2025 figures confirm that CNTC remains not only the world’s largest tobacco company by volume, revenue and profit, but also one of the most consequential fiscal actors within China’s public finance system.
January 2026: China Tobacco Sets New Growth Drivers for 2026 at Annual Meeting
At its annual tobacco industry meeting in Beijing on January 18-19, 2026, China’s tobacco authorities outlined strategic priorities aimed at fostering growth in a slowing traditional tobacco market. Officials from the State Tobacco Monopoly Administration (STMA) and China National Tobacco Corporation (CNTC) emphasized that alongside maintaining stability and strengthening regulatory oversight, the sector must cultivate new growth drivers to sustain long-term development. The four key focus areas identified were: innovation in Chinese-style cigarettes, boosting the profitability of domestically produced cigars, expanding overseas business, and advancing multi-purpose utilization of tobacco resources.
The push for cigarette innovation reflects ongoing efforts to reinvigorate demand for traditional products amid declining smoking rates and tighter regulation affecting new nicotine categories. Meanwhile, domestic cigars were highlighted as a significant opportunity, with China’s cigar market – both in production and consumption – showing substantial growth potential. In fact, China’s cigar imports and domestic interest have surged in recent years, with import values almost tripling between 2021 and 2023, signaling rising consumer demand that could boost local premium cigar development.
Expanding overseas business is another core component of the strategy, aligning with broader globalization ambitions within China’s tobacco sector. For example, China Tobacco International recently inked a global distribution deal to promote its Great Wall cigars across markets beyond duty-free zones, aiming to build a unified international presence for Chinese cigars and unlock new revenue streams abroad.
Finally, the meeting pointed to multi-purpose use of tobacco – exploring value beyond conventional products. This could include leveraging tobacco leaf and nicotine for applications in biotechnology, materials science, pharmaceuticals, and industrial inputs, though specific implementation plans were not detailed. Officials also reiterated the importance of strengthening market oversight, particularly of e-cigarettes and other novel products – a theme consistent with China’s broader regulatory tightening in recent months, as authorities invite public input on 2026 e-cigarette standards and crack down on excess capacity and non-compliance in the sector.
In summary, China’s tobacco leadership is seeking to balance traditional product stability with innovation and diversification, leveraging new product formats, global expansion, and cross-industry applications to offset pressures from regulation and shifting consumer habits.
Market Overview
China is by far the world’s largest cigarette market and the state monopoly, China National Tobacco Corporation (CNTC in short or commonly known as China Tobacco) is by far the world’s largest tobacco company. In 2023, CNTC recorded a revenue of about CN¥1.5 trillion (US$210 billion), which is up 4.3% from the previous year1 and six times the net revenue of Philip Morris International (PMI), the second-largest tobacco company.
With more than 300 million smokers, China has the most cigarette smokers in the world, making up nearly a third of the smokers in the world. Roughly speaking, there are as many smokers in China as the people in the USA. In such a gigantic market, China Tobacco – founded in 1982 with the purpose of bringing the industry under one centrally governed umbrella – makes up 97% of the tobacco production & sales while also closely controlling the rest of the market through quotas. China Tobacco is estimated to be contribute as much as 12% to China’s tax revenue and functions as both a company and a regulatory agency for the Chinese tobacco market.
Of the 5.18 trillion sticks of cigarettes sold globally in 2023, 2.44 trillion or 47% were sold in China. In other words, the global cigarette market is divided into two roughly equal pieces: China monopolized by CNTC and the Rest-of-the-World dominated by 5 major tobacco companies. Chinese market is practically closed to the international tobacco companies as the Western brands, for instance those of PMI and BAT, are sold in China through licensing agreements with China Tobacco and are subject to strict quotas.
The cigarette sales in China is still growing, even if sluggishly, while the cigarette sales elsewhere is declining by low single-digit (2%-3%) per annum. Most recently, increasing popularity of slim and super-slim cigarettes (“often advertised as low-tar and perceived as less harmful”) and emergence of various flavored cigarettes are the new cigarette volume drivers in China. Moreover, the availability of alternative nicotine products – which tend to speed up the cigarette volume decline – is also closely controlled by CNTC in China. For further details: China: E-cigarette Market.
International expansion has long been an ambition for CTNC. As of 2019, China Tobacco expanded its global reach to 20 countries and operates through 34 off-shore facilities (sales offices, manufacturing plants and specialized tobacco procurement companies). An important piece of recent expansion is CNTC’s China Tobacco International HK (CTI) subsidiary which is established to engage in the sales, importation and exportation of cigarettes & tobacco leaf and had its IPO on the Hong Kong Stock Exchange in June 2019. CNTC’s focus on exports has already started to bear its fruits with China’s tobacco exports reporting +22.2% annual growth to reach US$9.2 billion in 2023.
